| 产品详情 |
| Edit |   |
|---|
| Product Name | Gardiquimod |
|---|
| Description | Purity >95%. Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8. At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells. Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1. It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro . |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-amino-2-[(ethylamino)methyl]-a,a-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol |
|---|
| Gene, Accession, CAS # | CAS: 1020412-43-4 |
|---|
| Catalog # | LS-H7903 |
|---|
| Price | |
|---|
| Order / More Info | Gardiquimod from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|